· SBL executive management personnel, in cooperation with the 3i Group plc and SEB Företagsinvest, have acquired SBL Vaccin AB (SBL) from Chiron Vaccines, a business unit of the US-based Chiron Corporations Inc.

· SBL develops, manufactures, markets and distributes vaccines. The company's products include Dukoral®, an oral vaccine that provides protection against cholera. It is also used to prevent so-called travelers' diarrhoea.

· Dukoral® has been successfully sold in Sweden and Norway for several years and was recently approved for sale in all EU countries.

SBL's executive management, in cooperation with 3i and SEB Företagsinvest, have established a jointly owned company and acquired all shares in SBL. As a result of the acquisition, SBL will be developed as an independent company under industry-neutral ownership, which will support the company's future expansion. Under terms of the agreement, Chiron Vaccines will market Dukoral in some of the most...